206 - Utrogestan supply issues: what it means and alternatives available

The supply of HRT medication Utrogestan is being restricted by the UK government because of shortages amid increase demand. Pharmacies will only dispense two months’ worth of Utrogestan 100mg capsules per prescription to help ensure continued access for women. In this special episode, Newson Health pharmacist prescriber and menopause specialist Faiza Kennedy joins Dr Louise to talk about the restrictions, and where and how to seek advice and help. They talk about the importance of taking a progesterone as part of your HRT regime if you still have a womb, as well as alternatives to Utrogestan, including progesterone in pessary form, the Mirena coil and combined forms of HRT containing both estrogen and progesterone. Faiza’s top three tips:  Only order the amount of Utrogestan you need to help everyone get through the shortfall Be organised about ordering your HRT prescriptions. Do it about two weeks before you run out so you have time in case you have any difficulties getting your supply or need to seek an alternative Reach out for help if you are struggling with your supply Click here for a balance article for more information about the current Utrogestan supply restrictions, plus alternatives. You can read more about Faiza here.

Om Podcasten

Have a menopause question? You’ll find the answers here. Join me, GP and Menopause Specialist Dr Louise Newson, for the definitive perimenopause and menopause podcast. Each week I’m joined by a special guest for the lowdown on the latest research and treatments, bust myths and share inspirational stories. This podcast is brought to you by the Newson Health Group, which has clinics across the UK dedicated to providing personalised perimenopause and menopause care for all women. It funds cutting-edge menopause research and creates clinical-led education programmes for healthcare professionals. It also funds the award-winning balance menopause support app, which provides free menopause resources and support to millions of people worldwide, empowering and enabling women to have choice and control over their perimenopause and menopause treatment.